Highlights of New COVID Research

Did the COVID Groundhog See Its Shadow?

Friday, February 3, 2023

This newsletter is 313 words or a 2.5 minute read

Evusheld is no longer authorized for use in the United States

Evusheld is unlikely to be active against more than 90% of the COVID-19 variants currently circulating in the U.S. Providers must discontinue use of Evusheld.

People who have received Evusheld still have ways to increase their protection against severe COVID-19: maximize ventilation, vaccination, testing, and treatment. A positive test is no longer required to prescribe treatment.  

• No-cost telehealth visit and treatment: Virtual COVID-19 Visit for Californians
• Find a testing or treatment site: English / Spanish
• Optum test-to-treat sites test for flu and COVID: Appointment Registration
• Call 619-685-2500 or visit FHCSD COVID-19 Treatment to access remdesivir

What will happen when the COVID-19 public health emergency (PHE) ends? 

As the PHE declarations end (February 28th in California and May 11th in the U.S.) access to COVID-19 vaccines, tests, treatments, and telehealth may change.

What Happens When COVID-19 Emergency Declarations End? Implications for Coverage, Costs, and Access

Vaccines required for healthcare personnel (HCP)

CDPH released AFL 21-34 to clarify that all HCP who provide services or work in health care facilities must be vaccinated and boosted for COVID-19, unless exempt. 

The routine testing of exempt HCP and booster-eligible HCP who have not yet received their booster is no longer required.

Missed the meeting? We have you covered!

Email us at MCS@sdcounty.ca.gov for CME credit

Please see below for informational resources.

• Telebriefing Slides (pdf)
• Recording of the meeting will be available until Wednesday, February 8th at midnight.

   Download PDF of slides to access all links.

Scan the QR code or click below to connect with Medical Care Services Outreach and Education!